Does Sleeve Gastrectomy Increase the Risk of Barret's Esophagus?


Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 21 03 2020
accepted: 22 07 2020
revised: 20 07 2020
pubmed: 30 7 2020
medline: 20 4 2021
entrez: 30 7 2020
Statut: ppublish

Résumé

Sleeve gastrectomy (SG) is the most commonly performed bariatric surgical procedure worldwide. However, the impact of SG on Barrett's esophagus (BE) remains unknown. The main objective was to determine the rate of BE 5 years after SG. Patients, operated in 2012 by SG in one center, who preoperatively and postoperatively (5 years) underwent upper gastrointestinal endoscopy (UGIE), 24-h pH monitoring, and esophageal manometry, were included. A total of 59 (81.4% of females) patients were included. Preoperative mean age and body mass index were 45.2 ± 11.7 years and 45.2 ± 8.1 kg/m This study highlights the incidence of postoperative GERD and endoscopic lesions following SG. Even though SG is not contraindicated in case of reflux, GERD patients who undergo SG may be supervised by a close endoscopic surveillance.

Identifiants

pubmed: 32725593
doi: 10.1007/s11695-020-04875-9
pii: 10.1007/s11695-020-04875-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101-110

Références

Thereaux J, Lesuffleur T, Czernichow S, et al. Do sleeve gastrectomy and gastric bypass influence treatment with proton pump inhibitors 4 years after surgery? A nationwide cohort. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2017;13(6):951–9. https://doi.org/10.1016/j.soard.2016.12.013 .
doi: 10.1016/j.soard.2016.12.013
Himpens J, Ramos A, Welbourn R, Dixon J, Kinsman R, Walton P. IFSO Global Registry Report 2018. :84.
Sebastianelli L, Benois M, Vanbiervliet G, Bailly L., Robert M., Turrin N., Gizard E., Foletto M., Bisello M., Albanese A., Santonicola A., Iovino P., Piche T., Angrisani L., Turchi L., Schiavo L., Iannelli A. Systematic endoscopy 5 years after sleeve gastrectomy results in a high rate of Barrett’s esophagus: results of a multicenter study. Obes Surg Published online January 21, 2019. doi: https://doi.org/10.1007/s11695-019-03704-y , 1462, 1469
Falk GW. Barrett’s esophagus: frequency and prediction of dysplasia and cancer. Best Pract Res Clin Gastroenterol. 2015;29(1):125–38. https://doi.org/10.1016/j.bpg.2015.01.001 .
doi: 10.1016/j.bpg.2015.01.001 pubmed: 25743461 pmcid: 4352690
Musella M, Berardi G, Bocchetti A, et al. Esophagogastric neoplasms following bariatric surgery: an updated systematic review. Obes Surg. 2019;29(8):2660–9. https://doi.org/10.1007/s11695-019-03951-z .
doi: 10.1007/s11695-019-03951-z pubmed: 31129886
Communiqué no.3 : Surveillance endoscopique après sleeve gastrectomie et bypass en oméga définie par la SOFFCO.MM - SOFFCO.MM. Accessed June 2, 2019. https://soffcomm.org/communique-ndeg3-surveillance-endoscopique-apres-sleeve-gastrectomie-et-bypass-en-omega-definie-par
Obésité : prise en charge chirurgicale chez l’adulte. Haute Autorité de Santé. Accessed July 22, 2019. https://www.has-sante.fr/jcms/c_765529/fr/obesite-prise-en-charge-chirurgicale-chez-l-adulte
Association AD. 1. Improving care and promoting health in populations: standards of medical care in diabetes-2020. Diabetes Care 2020;43(Suppl 1):S7-S13. doi: https://doi.org/10.2337/dc20-S001
Spechler SJ, Zeroogian JM, Antonioli DA, et al. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet Lond Engl. 1994;344(8936):1533–6. https://doi.org/10.1016/s0140-6736(94)90349-2 .
doi: 10.1016/s0140-6736(94)90349-2
Pohl H, Pech O, Arash H, et al. Length of Barrett’s oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma. Gut. 2016;65(2):196–201. https://doi.org/10.1136/gutjnl-2015-309220 .
doi: 10.1136/gutjnl-2015-309220 pubmed: 26113177
Braghetto I, Csendes A. Prevalence of Barrett’s esophagus in bariatric patients undergoing sleeve gastrectomy. Obes Surg. 2016;26(4):710–4. https://doi.org/10.1007/s11695-015-1574-1 .
doi: 10.1007/s11695-015-1574-1 pubmed: 25855575
Felsenreich DM, Kefurt R, Schermann M, et al. Reflux, sleeve dilation, and Barrett’s esophagus after laparoscopic sleeve gastrectomy: long-term follow-up. Obes Surg. 2017;27(12):3092–101. https://doi.org/10.1007/s11695-017-2748-9 .
doi: 10.1007/s11695-017-2748-9 pubmed: 28593484
Ishimura N, Amano Y, Uno G, et al. Endoscopic characteristics of short-segment Barrett’s esophagus, focusing on squamous islands and mucosal folds. J Gastroenterol Hepatol. 2012;27(Suppl 3):82–7. https://doi.org/10.1111/j.1440-1746.2012.07079.x .
doi: 10.1111/j.1440-1746.2012.07079.x pubmed: 22486877
Meining A, Ott R, Becker I, et al. The Munich Barrett follow up study: suspicion of Barrett’s oesophagus based on either endoscopy or histology only--what is the clinical significance? Gut. 2004;53(10):1402–7. https://doi.org/10.1136/gut.2003.036822 .
doi: 10.1136/gut.2003.036822 pubmed: 15361485 pmcid: 1774245
Felsenreich DM, Langer FB, Prager G. Weight loss and resolution of comorbidities after sleeve gastrectomy: a review of long-term results. Scand J Surg SJS Off Organ Finn Surg Soc Scand Surg Soc. Published online September 6, 2018:1457496918798192. https://doi.org/10.1177/1457496918798192
Wright FG, Duro A, Medici JR, et al. Esophageal adenocarcinoma five years after laparoscopic sleeve gastrectomy. A case report. Int J Surg Case Rep. 2017;32:47–50. https://doi.org/10.1016/j.ijscr.2017.01.054 .
doi: 10.1016/j.ijscr.2017.01.054 pubmed: 28235650 pmcid: 5322173
Scheepers AF, Schoon EJ, Nienhuijs SW. Esophageal carcinoma after sleeve gastrectomy. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2011;7(4):e11–2. https://doi.org/10.1016/j.soard.2010.09.019 .
doi: 10.1016/j.soard.2010.09.019
Sohn S, Fischer J, Booth M. Adenocarcinoma of the gastro-oesophageal junction after sleeve gastrectomy: a case report. ANZ J Surg. 2017;87(10):E163–4. https://doi.org/10.1111/ans.13064 .
doi: 10.1111/ans.13064 pubmed: 25827159
Genco A, Soricelli E, Casella G, et al. Gastroesophageal reflux disease and Barrett’s esophagus after laparoscopic sleeve gastrectomy: a possible, underestimated long-term complication. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2017;13(4):568–74. https://doi.org/10.1016/j.soard.2016.11.029 .
doi: 10.1016/j.soard.2016.11.029
Thereaux J, Barsamian C, Bretault M, et al. pH monitoring of gastro-oesophageal reflux before and after laparoscopic sleeve gastrectomy. Br J Surg. 2016;103(4):399–406. https://doi.org/10.1002/bjs.10089 .
doi: 10.1002/bjs.10089 pubmed: 26806096
Borbély Y, Schaffner E, Zimmermann L, et al. De novo gastroesophageal reflux disease after sleeve gastrectomy: role of preoperative silent reflux. Surg Endosc Published online July 12, 2018, 789, 793 https://doi.org/10.1007/s00464-018-6344-4
Yeung KTD, Penney N, Ashrafian L, et al. Does sleeve gastrectomy expose the distal esophagus to severe reflux?: a systematic review and meta-analysis. Ann Surg Published online March 20, 2019. 257, 265 https://doi.org/10.1097/SLA.0000000000003275
Rebecchi F, Allaix ME, Giaccone C, et al. Gastroesophageal reflux disease and laparoscopic sleeve gastrectomy: a physiopathologic evaluation. Ann Surg. 2014;260(5):909–15. https://doi.org/10.1097/SLA.0000000000000967 .
doi: 10.1097/SLA.0000000000000967 pubmed: 25379861
Sioka E, Tzovaras G, Perivoliotis K, et al. Impact of laparoscopic sleeve gastrectomy on gastrointestinal motility. Gastroenterol Res Pract. 2018;2018:4135813–7. https://doi.org/10.1155/2018/4135813 .
doi: 10.1155/2018/4135813 pubmed: 29849586 pmcid: 5907392
Braghetto et al. Late esophagogastric anatomic and functional changes after sleeve gastrectomy and its clinical consequences with regards to gastroesophageal reflux... - PubMed - NCBI. Accessed August 6, 2019. https://www.ncbi.nlm.nih.gov/pubmed/31076757
Braghetto I, Lanzarini E, Korn O, et al. Manometric changes of the lower esophageal sphincter after sleeve gastrectomy in obese patients. Obes Surg. 2010;20(3):357–62. https://doi.org/10.1007/s11695-009-0040-3 .
doi: 10.1007/s11695-009-0040-3 pubmed: 20013071
Howard DD, Caban AM, Cendan JC, et al. Gastroesophageal reflux after sleeve gastrectomy in morbidly obese patients. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2011;7(6):709–13. https://doi.org/10.1016/j.soard.2011.08.003 .
doi: 10.1016/j.soard.2011.08.003
DuPree CE, Blair K, Steele SR, et al. Laparoscopic sleeve gastrectomy in patients with preexisting gastroesophageal reflux disease : a national analysis. JAMA Surg. 2014;149(4):328–34. https://doi.org/10.1001/jamasurg.2013.4323 .
doi: 10.1001/jamasurg.2013.4323 pubmed: 24500799
De Luca M, Angrisani L, Himpens J, et al. Indications for surgery for obesity and weight-related diseases: position statements from the International Federation for the Surgery of obesity and metabolic disorders (IFSO). Obes Surg. 2016;26(8):1659–96. https://doi.org/10.1007/s11695-016-2271-4 .
doi: 10.1007/s11695-016-2271-4 pubmed: 27412673 pmcid: 27412673
Holmberg D, Santoni G, Xie S, et al. Gastric bypass surgery in the treatment of gastro-oesophageal reflux symptoms. Aliment Pharmacol Ther. 2019;50(2):159–66. https://doi.org/10.1111/apt.15274 .
doi: 10.1111/apt.15274 pubmed: 31165515
Nocca D, Skalli EM, Boulay E, et al. Nissen sleeve (N-sleeve) operation: preliminary results of a pilot study. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2016;12(10):1832–7. https://doi.org/10.1016/j.soard.2016.02.010 .
doi: 10.1016/j.soard.2016.02.010
Desart K, Rossidis G, Michel M, et al. Gastroesophageal reflux management with the LINX® system for gastroesophageal reflux disease following laparoscopic sleeve gastrectomy. J Gastrointest Surg Off J Soc Surg Aliment Tract. 2015;19(10):1782–6. https://doi.org/10.1007/s11605-015-2887-z .
doi: 10.1007/s11605-015-2887-z
Sharara AI, Rustom LBO, Bou Daher H, et al. Prevalence of gastroesophageal reflux and risk factors for erosive esophagitis in obese patients considered for bariatric surgery Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver Published online May 7, 2019, 1375, 1379 https://doi.org/10.1016/j.dld.2019.04.010
Emmanuelli J, Maymil V, Naves P. Rapport IGAS - situation de la chirurgie de l’obésité. Published online January 2018.
Lyon A, Gibson SC, De-loyde K, et al. Gastroesophageal reflux in laparoscopic sleeve gastrectomy: hiatal findings and their management influence outcome. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2015;11(3):530–7. https://doi.org/10.1016/j.soard.2014.08.010 .
doi: 10.1016/j.soard.2014.08.010
International Sleeve Gastrectomy Expert Panel Consensus Statement: best practice guidelines based on experience of >12,000 cases. Surg Obes Relat Dis. 2012;8(1):8–19. https://doi.org/10.1016/j.soard.2011.10.019
Spivak H, Rubin M, Sadot E, et al. Laparoscopic sleeve gastrectomy using 42-French versus 32-French bougie: the first-year outcome. Obes Surg. 2014;24(7):1090–3. https://doi.org/10.1007/s11695-014-1199-9 .
doi: 10.1007/s11695-014-1199-9 pubmed: 24577879
Wang Y, Yi X-Y, Gong L-L, et al. The effectiveness and safety of laparoscopic sleeve gastrectomy with different sizes of bougie calibration: a systematic review and meta-analysis. Int J Surg Lond Engl. 2018;49:32–8. https://doi.org/10.1016/j.ijsu.2017.12.005 .
doi: 10.1016/j.ijsu.2017.12.005
McGlone ER, Gupta AK, Reddy M, et al. Antral resection versus antral preservation during laparoscopic sleeve gastrectomy for severe obesity: systematic review and meta-analysis. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2018;14(6):857–64. https://doi.org/10.1016/j.soard.2018.02.021 .
doi: 10.1016/j.soard.2018.02.021

Auteurs

L Lallemand (L)

Chirurgie Cancérologique, Digestive et Endocrinienne (CCDE), Institut des Maladies de l'Appareil Digestif (IMAD), Centre Hospitalo-universitaire de Nantes (CHU) Hôtel-Dieu, Place Alexis Ricordeau, 44093, Nantes, France.

E Duchalais (E)

Chirurgie Cancérologique, Digestive et Endocrinienne (CCDE), Institut des Maladies de l'Appareil Digestif (IMAD), Centre Hospitalo-universitaire de Nantes (CHU) Hôtel-Dieu, Place Alexis Ricordeau, 44093, Nantes, France.
Université de Nantes, quai de Tourville, 44000, Nantes, France.

N Musquer (N)

Service d'Hépato-Gastroentérologie et Assistance Nutritionnelle, Institut des Maladies de l'Appareil Digestif (IMAD), Centre Hospitalo-Universitaire (CHU), Nantes, France.

D Jacobi (D)

Université de Nantes, quai de Tourville, 44000, Nantes, France.
L'Institut du Thorax, Service d'Endocrinologie, Maladies Métaboliques et Nutrition, CHU Nantes, Nantes, France.
L'Institut du Thorax, Inserm UMR-S1087, CNRS, UNIV Nantes, Nantes, France.

E Coron (E)

Université de Nantes, quai de Tourville, 44000, Nantes, France.
Service d'Hépato-Gastroentérologie et Assistance Nutritionnelle, Institut des Maladies de l'Appareil Digestif (IMAD), Centre Hospitalo-Universitaire (CHU), Nantes, France.

S Bruley des Varannes (SB)

Université de Nantes, quai de Tourville, 44000, Nantes, France.
Service d'Hépato-Gastroentérologie et Assistance Nutritionnelle, Institut des Maladies de l'Appareil Digestif (IMAD), Centre Hospitalo-Universitaire (CHU), Nantes, France.

E Mirallié (E)

Chirurgie Cancérologique, Digestive et Endocrinienne (CCDE), Institut des Maladies de l'Appareil Digestif (IMAD), Centre Hospitalo-universitaire de Nantes (CHU) Hôtel-Dieu, Place Alexis Ricordeau, 44093, Nantes, France.
Université de Nantes, quai de Tourville, 44000, Nantes, France.

C Blanchard (C)

Chirurgie Cancérologique, Digestive et Endocrinienne (CCDE), Institut des Maladies de l'Appareil Digestif (IMAD), Centre Hospitalo-universitaire de Nantes (CHU) Hôtel-Dieu, Place Alexis Ricordeau, 44093, Nantes, France. claire.blanchard@chu-nantes.fr.
Université de Nantes, quai de Tourville, 44000, Nantes, France. claire.blanchard@chu-nantes.fr.
L'Institut du Thorax, Service d'Endocrinologie, Maladies Métaboliques et Nutrition, CHU Nantes, Nantes, France. claire.blanchard@chu-nantes.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH